Skip to content

Intended useFor research use only. Not for human or veterinary use.

Goldkern Lexicon

BPC-157

Author
Redaktion GOLDKERN (Demo)
Expert review
Expert review pending
Last reviewed
not yet reviewed

Overview

BPC-157 is a synthetic linear peptide of 15 amino acids (a pentadecapeptide) with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. According to the original authors, the sequence derives from a protein isolated from human gastric juice. This entry covers structure, origin and analytical aspects only.

Scientific background

Classification and nomenclature

BPC-157 is a short, linear oligopeptide without disulfide bridges or other modifications. The abbreviation BPC stands for ‘body protection compound’, a name introduced in the early 1990s by the group led by Predrag Sikirić at the University of Zagreb. Substance databases also list synonyms such as PL 14736 and Bepecin. According to the original authors, it is a partial sequence of a larger protein obtained from gastric juice; independent characterisation of this parent protein is scarcely documented in the accessible literature.

Structure and composition

In the one-letter code the sequence reads GEPPPGKPADDAGLV. Notable features are the high proportion of proline (four of 15 residues, including the motif Pro-Pro-Pro) and glycine (three residues). Proline-rich segments restrict backbone mobility and favour extended conformations. With one glutamic acid, two aspartic acids and the free C-terminus, the molecule carries more acidic than basic groups (lysine and the N-terminus); its net charge at neutral pH is therefore negative. The sequence contains no cysteine, methionine or tryptophan – none of the amino acids that are particularly susceptible to oxidation.

Molecular data

The molecular formula of the free peptide is C₆₂H₉₈N₁₆O₂₂ and its average molar mass 1419.5 g/mol (data from PubChem). The registered CAS number is 137525-51-0. Synthetically produced batches are generally present as salts; the actual weighed mass then also includes counterions and water, which has to be taken into account when stating content and concentration.

Analytical characterisation

Identity is usually confirmed by mass spectrometry via the calculated molecular mass, and chromatographic purity is determined by reversed-phase HPLC. Possible by-products of solid-phase synthesis for this sequence include deletion sequences in the proline-rich segments and side reactions at the aspartic acid residues (aspartimide formation). Which tests were carried out for a particular batch can be seen from the corresponding certificate of analysis.

Molecular data

Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular formula
C62H98N16O22
Molecular weight
1,419.5 g/mol
CAS number
137525-51-0

State of research

The published literature on BPC-157 consists predominantly of preclinical work, that is, cell culture and animal studies; a considerable proportion comes from the circle of the original authors, and independent replications are comparatively rare. An editorially reviewed summary of the state of research with verified sources is in preparation. This entry deliberately makes no statements about effects.

Sources

The sources for this entry are currently being verified by the editorial team and will appear once verified.

Safety and research notes

  • For research and analytical purposes only. Not for use in humans or animals.
  • The toxicological properties have not been fully investigated; handle the substance with appropriate caution.
  • Wear a lab coat, safety glasses and gloves; open powders only in a weighing enclosure or fume hood and do not inhale dust.
  • Follow the safety data sheet for the batch in question; dispose of residues and contaminated materials in accordance with local regulations.